intervention. Similarly, a phenomenon known as the Hawthorne effect may cause participants to report more favorable outcomes because they are receiving closer attention or being more closely evaluated as a result of participation in a study (McCarney et al., 2007) . Addition of a control group that would provide participants with a similar amount of attention and evaluation as the intervention group helps control for both social desirability bias and the Hawthorne effect.
Instrumentation
Another major threat to validity is instrumentation. Although no gold standard exists for measurement of CIPN (Dunlap & Paice, 2006) , there are several instruments available for measurement of CIPN that have demonstrated reliability and validity (Almadrones, McGuire, Walczak, Florio, & Tian, 2004; Huang, Brady, Cella, & Fleming, 2007; Tofthagen, McMillan, & Kip, 2011) . Eliciting patient preferences and perceptions regarding efficacy is an important aspect of patient care; however, opinions without the use of reliable and valid measures of the outcome variable should be avoided in clinical research. Valid instruments have undergone evaluation to determine the extent to which they actually measure the concept they intend to measure (Waltz, Strickland, & Lenz, 2005) . If a blood pressure cuff is used to measure temperature, even though the blood pressure cuff is working as it should, it is an invalid measure of temperature. Reliable instruments consistently produce the same results in the same circumstances. If the blood pressure cuff reveals hypertension on the first measurement and hypotension in the same hemodynamically stable patient 30 seconds later, that blood pressure cuff is an unreliable measure of blood pressure, at least until it can be calibrated and/or repaired. Just as using a valid and reliable instrument to measure blood pressure is important in practice, using valid and reliable measurement tools is equally important in research.
External validity refers to the generalizability of the findings to other samples. In interventional studies for CIPN, generalizing the results to a specific population may not be possible when participants differ in respect to factors that can be expected to influence outcomes such as cancer type, chemotherapy doses, and chemotherapy drugs. It is likely that patients who develop CIPN from one neurotoxic chemotherapy may differ in response from those who receive other types of neurotoxic chemotherapy.
Conclusion
Retrospective designs provide a vehicle for research using existing data but can be riddled with threats to both internal and external validity. Although a cause-and-effect relationship cannot be determined using retrospective studies, they are useful for providing preliminary data and in guiding the development of future prospective studies.
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